↓ Skip to main content

Inhibition of lipoprotein lipid oxidation.

Overview of attention for book
Cover of 'Inhibition of lipoprotein lipid oxidation.'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 The Pathogenesis of Atherosclerosis
  3. Altmetric Badge
    Chapter 2 Risk Factors for Atherosclerotic Vascular Disease
  4. Altmetric Badge
    Chapter 3 Metabolic Syndrome: Therapeutic Considerations
  5. Altmetric Badge
    Chapter 4 Physical activity, obesity and cardiovascular diseases.
  6. Altmetric Badge
    Chapter 5 Fatty acids and atherosclerotic risk.
  7. Altmetric Badge
    Chapter 6 Dietary cholesterol, atherosclerosis and coronary heart disease.
  8. Altmetric Badge
    Chapter 7 Plant Sterols and Stanols
  9. Altmetric Badge
    Chapter 8 Carbohydrates and Dietary Fiber
  10. Altmetric Badge
    Chapter 9 Dietary Antioxidants and Paraoxonases Against LDL Oxidation and Atherosclerosis Development
  11. Altmetric Badge
    Chapter 10 Soy, Isoflavones and Atherosclerosis
  12. Altmetric Badge
    Chapter 11 Homocysteine and B Vitamins
  13. Altmetric Badge
    Chapter 12 Alcohol
  14. Altmetric Badge
    Chapter 13 Lipid and Non-lipid Effects of Statins
  15. Altmetric Badge
    Chapter 14 Fibrates
  16. Altmetric Badge
    Chapter 15 ACE Inhibitors and Angiotensin II Receptor Antagonists
  17. Altmetric Badge
    Chapter 16 Inhibition of Platelet Activation and Aggregation
  18. Altmetric Badge
    Chapter 17 The ABC of Hepatic and Intestinal Cholesterol Transport
  19. Altmetric Badge
    Chapter 18 Inhibition of the Synthesis of Apolipoprotein B-Containing Lipoproteins
  20. Altmetric Badge
    Chapter 19 Therapy of Hyper-Lp(a)
  21. Altmetric Badge
    Chapter 20 Modulation of High-Density Lipoprotein Cholesterol Metabolism and Reverse Cholesterol Transport
  22. Altmetric Badge
    Chapter 21 Inhibition of Lipoprotein Lipid Oxidation
  23. Altmetric Badge
    Chapter 22 Correction of Insulin Resistance and the Metabolic Syndrome
  24. Altmetric Badge
    Chapter 23 Protection of Endothelial Function
  25. Altmetric Badge
    Chapter 24 Modulation of Smooth Muscle Cell Proliferation and Migration: Role of Smooth Muscle Cell Heterogeneity
  26. Altmetric Badge
    Chapter 25 Modulation of Macrophage Function and Metabolism
  27. Altmetric Badge
    Chapter 26 Inflammation Is a Crucial Feature of Atherosclerosis and a Potential Target to Reduce Cardiovascular Events
  28. Altmetric Badge
    Chapter 27 Autoimmune Mechanisms of Atherosclerosis
  29. Altmetric Badge
    Chapter 28 Drug Therapies to Prevent Coronary Plaque Rupture and Erosion: Present and Future
  30. Altmetric Badge
    Chapter 29 Reciprocal Role of Vasculogenic Factors and Progenitor Cells in Atherogenesis
  31. Altmetric Badge
    Chapter 30 Gene Therapy of Atherosclerosis
Attention for Chapter 5: Fatty acids and atherosclerotic risk.
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)

Mentioned by

twitter
1 X user
wikipedia
6 Wikipedia pages

Readers on

mendeley
19 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Fatty acids and atherosclerotic risk.
Chapter number 5
Book title
Atherosclerosis: Diet and Drugs
Published in
Handbook of experimental pharmacology, April 2006
DOI 10.1007/3-540-27661-0_5
Pubmed ID
Book ISBNs
978-3-54-022569-0, 978-3-54-027661-6
Authors

Thijssen MA, Mensink RP, Thijssen, M.A., Mensink, R.P., M.A. Thijssen, R.P. Mensink

Abstract

Most research concerning the effects of dietary fatty acids on atherosclerotic risk has focused on their effects on lipid and lipoprotein metabolism. However, it is known that fatty acids also influence a number of other relevant mechanisms involved in atherosclerosis such as lipid peroxidation, inflammation and haemostasis. The most favourable distribution of cholesterol over the various lipoproteins is achieved when saturated and trans fatty acids are replaced by a mixture of cis-unsaturated fatty acids. Furthermore, fatty acids from fish oil lower triacylglycerol concentrations. Effects on other atherosclerotic risk markers are less evident. Monounsaturated fatty acids maybe preferable above other fatty acids with respect to low-density lipoprotein oxidation as measured by indirect in vitro assays. The relevance of these assays for the in vivo situation is, however, limited. With respect to inflammation, mainly the effects of n-3 polyunsaturated fatty acids from fish oil have been studied, but results were inconsistent. Also results from studies evaluating the effects of fatty acids on haemostatic risk markers were inconsistent, which may be partly related to the use of different analytical methods. The most consistent finding however is the potential beneficial effect of moderate intakes of fish oil on platelet aggregation. Furthermore, reducing total fat intake rather than changing the fatty acid composition of the diet may beneficially affect the coagulation system. In conclusion, while beneficial effects on atherosclerotic risk are mainly ascribed to cis-unsaturated fatty acids, it remains debateable whether trans and saturated fatty acids in the diet have to be replaced by cis-unsaturated fatty acids or by carbohydrates. To answer this question adequately more validated methods are needed that reflect in vivo lipid peroxidation, inflammation and haemostasis.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 5%
Unknown 18 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 26%
Student > Master 3 16%
Researcher 2 11%
Professor 1 5%
Lecturer 1 5%
Other 1 5%
Unknown 6 32%
Readers by discipline Count As %
Agricultural and Biological Sciences 4 21%
Biochemistry, Genetics and Molecular Biology 4 21%
Medicine and Dentistry 2 11%
Social Sciences 1 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Other 0 0%
Unknown 7 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 February 2024.
All research outputs
#7,482,248
of 23,524,722 outputs
Outputs from Handbook of experimental pharmacology
#232
of 652 outputs
Outputs of similar age
#23,233
of 67,089 outputs
Outputs of similar age from Handbook of experimental pharmacology
#10
of 13 outputs
Altmetric has tracked 23,524,722 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 652 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 67,089 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.